Discontinuation report SANDOZ OMEPRAZOLE

Last updated on 2024-04-04 History
Report ID 224216
Drug Identification Number 02296446
Brand name SANDOZ OMEPRAZOLE
Common or Proper name OMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OMEPRAZOLE
Strength(s) 20MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 100GRC BO
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2024-04-03
Remaining supply date 2024-04-03
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-04-04 English Compare
v4 2024-04-03 French Compare
v3 2024-04-03 English Compare
v2 2024-04-03 French Compare
v1 2024-04-03 English Compare

Showing 1 to 5 of 5